Germany Seeks PTC Therapeutics (PTCT) Translarna Discount - Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Wedbush Downgrades PTC Therapeutics (PTCT) to Neutral
March 1, 2016 7:29 AM ESTWedbush downgraded PTC Therapeutics (NASDAQ: PTCT) from Outperform to Neutral with a price target of $11.00 (from $27.00), saying lower Translarna estimates shift risk/reward.
Analyst Heather Behanna commented, "Though we still believe Translarna has a good chance of full EU approval, we are... More
Cowen Downgrades PTC Therapeutics (PTCT) to Market Perform
March 1, 2016 7:27 AM ESTCowen downgraded PTC Therapeutics (NASDAQ: PTCT) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on PTC Therapeutics click here. For more ratings news on PTC Therapeutics click here.
Shares of PTC Therapeutics closed at $7.98 yesterday.
... MoreBofA/Merrill Lynch Downgrades PTC Therapeutics (PTCT) to Neutral
February 29, 2016 8:58 AM ESTBofA/Merrill Lynch downgraded PTC Therapeutics (NASDAQ: PTCT) from Buy to Neutral.
For an analyst ratings summary and ratings history on PTC Therapeutics click here. For more ratings news on PTC Therapeutics click here.
Shares of PTC Therapeutics closed at $7.99 yesterday.
... MorePTC Therapeutics (PTCT) Offers Update on German Pricing and Reimbursement Process for Translarna
February 26, 2016 4:02 PM ESTPTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company has had multiple discussions with the German Federal Association of the Statutory Health Insurances (GKV-SV) over the last several months to come to agreement on pricing and reimbursement. Recently, these discussions transitioned into an arbitration process, which did... More
PTC Therapeutics (PTCT) Shares Decline; German Reimbursement Arbitration Panel Said to Cut Price of Ataluren by 65%
February 26, 2016 3:37 PM ESTPTC Therapeutics (NASDAQ: PTCT) declined Friday after theStreet's Feuerstein said the German reimbursement arbitration panel cuts the price of its DMD drug ataluren by 65%.
BREAKING $PTCT: German reimbursement arbitration panel cuts price of DMD drug ataluren by 65%. (Decision Feb. 25) pic.twitter.com/dPyMdza7U5
Adam Feuerstein (@adamfeuerstein) February 26, 2016... More
